Sherrington Pharmaceuticals Private Limited
About Sherrington Pharmaceuticals Private Limited
Data last updated:
Sherrington Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 October 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG2002PTC039741. Its GSTIN is 36AAHCS7292L1ZN (Telangana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Manogna Yeluri (Managing Director) and Yeluri Hari Prasad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Avm Towers No.4 2nd Floor Opp Kphb Col Near Shivaparvathi Theater Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2024, the company reported a revenue of ₹22.55 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹19.09 Lakh (net margin 0.8%) and EBITDA of ₹41.28 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 4% over five years.
The company is associated with 1 brand: Yeluri. As per MCA filings, the company has open charges of ₹76.28 Cr and satisfied charges of ₹1.62 Cr on record. Court records list 5 cases involving the company, including 4 filed by the company and 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Sherrington Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231AP2002PTC039741. The current CIN is U24231TG2002PTC039741, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG2002PTC039741 | Current |
| U24231AP2002PTC039741 | Previous |
Contact details
Sherrington Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressAvm Towers No.4 2nd Floor Opp Kphb Col Near Shivaparvathi Theater Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sherrington Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Sherrington Pharmaceuticals operates one associated brand: Yeluri. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures traditional pharmaceutical formulations for the healthcare industry. | yeluri.net |
Business activity
The main business activity of Sherrington Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sherrington Pharmaceuticals Private Limited, buy the company report.
Financials of Sherrington Pharmaceuticals Private Limited
FY 2025 filings availableSherrington Pharmaceuticals Private Limited reported revenue of ₹22.55 Cr (up 3% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 3% growth in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹41.28 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sherrington Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sherrington Pharmaceuticals Private Limited
Sherrington Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manogna Yeluri | Managing Director | 19 Aug 2019 | 7 Years 2 Months | Current |
| Yeluri Hari Prasad | Director | 09 Oct 2002 | 24 Years 0 Months | Current |
Peer comparison
Sherrington Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Parul Pharmaceuticals Private Limited | ₹22.59 Cr (FY 2024) | 62.0% | Vadodara, Gujarat, India | |||
| Mapaex Remedies Private Limited | ₹22.57 Cr (FY 2017) | -52.0% | Wadhwan, Gujarat, India | |||
| Athulitha Laboratories Private Limited | ₹22.56 Cr (FY 2024) | 66.0% | Hyderabad, Telangana, India | |||
| Beryl Drugs Limited | ₹22.55 Cr (FY 2025) | -17.0% | Indore, Madhya Pradesh, India | |||
| Sherrington Pharmaceuticals Private Limitedthis company | ₹22.55 Cr (FY 2024) | ₹19.09 Lakh | 0.8% | 3.0% | Hyderabad, Telangana, India | |
| Relief Biotech Private Limited | ₹22.54 Cr (FY 2025) | -25.0% | Roorkee, Uttarakhand, India | |||
| Ancalima Lifesciences Limited | ₹22.53 Cr (FY 2024) | 4.0% | Sonipat, Haryana, India | |||
| Cito Chem Industries Pvt.Ltd. | ₹22.46 Cr (FY 2025) | -18.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Sherrington Pharmaceuticals Private Limited, buy the company report.
Auditor
Sherrington Pharmaceuticals Private Limited is audited by AMARCHAND SHANTILAL & ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMARCHAND SHANTILAL & ASSOCIATES LLP | FY 2023 | 244333 |
Shareholding
The shareholding of Sherrington Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sherrington Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jan 2026 | 101235518 | Hdfc Bank Limited | ₹19.52 Lakh | Open | |
| 30 Jun 2022 | 100593146 | Hdfc Bank Limited | ₹21.08 Lakh | Open | |
| 03 Mar 2021 | 100424143 | Hdfc Bank Limited | ₹44.59 Cr | Open | |
| 21 Sep 2017 | 100126064 | Others | ₹20.74 Cr | Open | |
| 23 Aug 2011 | 10310420 | Ing Vysya Bank Limited | ₹8.55 Cr | Open |
To see the full charge records of Sherrington Pharmaceuticals Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Sherrington Pharmaceuticals Private Limited has 5 court cases on record: 4 filed by Sherrington Pharmaceuticals, 1 filed against it. 1 case is pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 0 |
| District courts | 2 | 1 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Writ petition | Filed by the company against The Southern Power Distribution Company of Telangana Ltd., and 2 others | Disposed |
| District court, BENGALURU, Karnataka | Court case (A.S.) | Filed against the company by M S Biovet Pvt Ltd | Disposed |
| High Court of Karnataka | Interim or miscellaneous application | Filed by the company against M/S Biovet Pvt Ltd | Disposed |
| High Court of Karnataka | Interim or miscellaneous application | Filed by the company against M/S Biovet Pvt Ltd | Disposed |
| District court, Medchal Malkajgiri, Telangana | Cheque dishonour complaint | Filed by the company against M/S Vizay Medical Corporation, Rep. by Its Proprietor and 1 other | Pending |
To see the full case history of Sherrington Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sherrington Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sherrington Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCS7292L1ZN | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sherrington Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sherrington Pharmaceuticals Private Limited has 4 board changes on record since 2002: 3 appointments and 1 cessation. The latest: Pasupathi Nadh Yeluri ceased to be Director on 10 Oct 2019.
6 earlier events are in the company report.
Frequently asked questions
Sherrington Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 October 2002 (24+ years old) and is registered under CIN U24231TG2002PTC039741.
Sherrington Pharmaceuticals has 2 current directors:
- Manogna Yeluri - Managing Director
- Yeluri Hari Prasad - Director
The latest financial statements of Sherrington Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sherrington Pharmaceuticals is 36AAHCS7292L1ZN, registered in Telangana.
The CIN (Corporate Identification Number) of Sherrington Pharmaceuticals is U24231TG2002PTC039741. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sherrington Pharmaceuticals has 5 court cases on record: 4 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Sherrington Pharmaceuticals was incorporated on 09 October 2002, making it 24+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sherrington Pharmaceuticals by revenue are Parul Pharmaceuticals Private Limited, Mapaex Remedies Private Limited, Athulitha Laboratories Private Limited, Beryl Drugs Limited, Relief Biotech Private Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pasupathi Nadh Yeluri ceased to be Director on 10 Oct 2019. Manogna Yeluri was appointed as Managing Director on 19 Aug 2019. Pasupathi Nadh Yeluri was appointed as Director on 26 Feb 2003. Sherrington Pharmaceuticals has 4 board changes on record in total.
The registered office of Sherrington Pharmaceuticals is at Avm Towers No.4 2nd Floor Opp Kphb Col Near Shivaparvathi Theater Kukatpally, Hyderabad, Telangana, India – 500072.
Sherrington Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.